Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 46
Filter
1.
J Environ Radioact ; 275: 107431, 2024 May.
Article in English | MEDLINE | ID: mdl-38626658

ABSTRACT

This paper analyses the formation of high Sr2+ concentration in strong alkaline (pH = 9.5-12.5) groundwater using data of the 27 years of observations around the destroyed Chernobyl NPP Unit 4. It appears that the formation of strong alkaline groundwater in different monitoring wells is consistent with the distribution of 90Sr, pH and main ions. The reason for the increase in 90Sr concentrations is the process of its migration from the sources of contamination - leaks of highly active water localized in certain premises inside the «Shelter ¼ object. These computational experiments showed that for the groundwater in pH range 9.5-12.4, the concentration of strontium in the form of SrOH + increases and in the form of Sr2+ - decreases. In addition, the fraction of 90Sr in the form of a soluble neutral complex compound SrCO30, which is not sorbed, reaches 14-35%. Increased fractions of 90Sr in forms of SrOH+ and SrCO3 are factors which reduce the isotope ability to be sorbed by soils and therefore increase its migration ability. In strongly alkaline groundwater a sharp increase in 90Sr volumetric activity may also be caused by ionic strength (IS) increase above 5 mmol/L. Thus, the factors that influence the increase in 90Sr volumetric activity in strongly alkaline groundwater are the formation of its complex compounds and an increase in ionic strength (IS), which reduces the thickness of the double electric layer and, as a result, reduces the sorption capacity of soils.


Subject(s)
Chernobyl Nuclear Accident , Groundwater , Radiation Monitoring , Strontium Radioisotopes , Water Pollutants, Radioactive , Strontium Radioisotopes/analysis , Groundwater/chemistry , Water Pollutants, Radioactive/analysis , Ukraine , Soil Pollutants, Radioactive/analysis
2.
Oper Dent ; 47(5): E241-E252, 2022 Sep 01.
Article in English | MEDLINE | ID: mdl-36026705

ABSTRACT

PURPOSE: The purpose of this study was to evaluate the leaching pattern of different types of polymer computer-aided design and computer-aided manufacturing (CAD-CAM) materials with a conventional resin composite. METHODS AND MATERIALS: Specimens of three representatives by type of polymer CAD-CAM blocks and one conventional resin composite were suspended using a silk thread in distilled water and artificial saliva. After one day, seven days, 14 days, 30 days, and 60 days, the analysis of the eluates for the detection of bisphenol A (BPA), urethane dimethacrylate (UDMA), triethylene glycol dimethacrylate (TEGDMA) and bisphenol A-glycidyl dimethacrylate (Bis-GMA) was quantified by utilizing high-performance liquid chromatography (HPLC). RESULTS: TEGDMA was the main eluted monomer for the polymer CAD-CAM materials for both solutions. However, there was a decreasing pattern throughout the tested period. On the contrary, there was a constant release of monomers from the conventional resin composite. Bisphenol-A was released only by the conventional resin composite and in both solutions chosen. CONCLUSIONS: Different types of polymer CAD-CAM materials release minimal or no monomers compared to the conventional resin composite material. The methods of fabrication of polymer CAD-CAM materials produces better properties than the conventional resin composite with a dramatic decrease of monomer elution.


Subject(s)
Composite Resins , Dental Materials , Bisphenol A-Glycidyl Methacrylate/chemistry , Composite Resins/chemistry , Computer-Aided Design , Dental Materials/chemistry , Materials Testing , Polyethylene Glycols , Polymers/chemistry , Polymethacrylic Acids , Saliva, Artificial , Silk , Water
3.
ESMO Open ; 6(5): 100254, 2021 10.
Article in English | MEDLINE | ID: mdl-34481329

ABSTRACT

BACKGROUND: The advanced lung cancer inflammation index [ALI: body mass index × serum albumin/neutrophil-to-lymphocyte ratio (NLR)] reflects systemic host inflammation, and is easily reproducible. We hypothesized that ALI could assist guidance of non-small-cell lung cancer (NSCLC) treatment with immune checkpoint inhibitors (ICIs). PATIENTS AND METHODS: This retrospective study included 672 stage IV NSCLC patients treated with programmed death-ligand 1 (PD-L1) inhibitors alone or in combination with chemotherapy in 25 centers in Greece and Germany, and a control cohort of 444 stage IV NSCLC patients treated with platinum-based chemotherapy without subsequent targeted or immunotherapy drugs. The association of clinical outcomes with biomarkers was analyzed with Cox regression models, including cross-validation by calculation of the Harrell's C-index. RESULTS: High ALI values (>18) were significantly associated with longer overall survival (OS) for patients receiving ICI monotherapy [hazard ratio (HR) = 0.402, P < 0.0001, n = 460], but not chemo-immunotherapy (HR = 0.624, P = 0.111, n = 212). Similar positive correlations for ALI were observed for objective response rate (36% versus 24%, P = 0.008) and time-on-treatment (HR = 0.52, P < 0.001), in case of ICI monotherapy only. In the control cohort of chemotherapy, the association between ALI and OS was weaker (HR = 0.694, P = 0.0002), and showed a significant interaction with the type of treatment (ICI monotherapy versus chemotherapy, P < 0.0001) upon combined analysis of the two cohorts. In multivariate analysis, ALI had a stronger predictive effect than NLR, PD-L1 tumor proportion score, lung immune prognostic index, and EPSILoN scores. Among patients with PD-L1 tumor proportion score ≥50% receiving first-line ICI monotherapy, a high ALI score >18 identified a subset with longer OS and time-on-treatment (median 35 and 16 months, respectively), similar to these under chemo-immunotherapy. CONCLUSIONS: The ALI score is a powerful prognostic and predictive biomarker for patients with advanced NSCLC treated with PD-L1 inhibitors alone, but not in combination with chemotherapy. Its association with outcomes appears to be stronger than that of other widely used parameters. For PD-L1-high patients, an ALI score >18 could assist the selection of cases that do not need addition of chemotherapy.


Subject(s)
Carcinoma, Non-Small-Cell Lung , Lung Neoplasms , Carcinoma, Non-Small-Cell Lung/drug therapy , Humans , Immune Checkpoint Inhibitors , Inflammation , Lung Neoplasms/drug therapy , Retrospective Studies
4.
Nat Commun ; 11(1): 2126, 2020 05 01.
Article in English | MEDLINE | ID: mdl-32358532

ABSTRACT

Many inland waters exhibit complete or partial desiccation, or have vanished due to global change, exposing sediments to the atmosphere. Yet, data on carbon dioxide (CO2) emissions from these sediments are too scarce to upscale emissions for global estimates or to understand their fundamental drivers. Here, we present the results of a global survey covering 196 dry inland waters across diverse ecosystem types and climate zones. We show that their CO2 emissions share fundamental drivers and constitute a substantial fraction of the carbon cycled by inland waters. CO2 emissions were consistent across ecosystem types and climate zones, with local characteristics explaining much of the variability. Accounting for such emissions increases global estimates of carbon emissions from inland waters by 6% (~0.12 Pg C y-1). Our results indicate that emissions from dry inland waters represent a significant and likely increasing component of the inland waters carbon cycle.

5.
Mol Biol Cell ; 28(22): 2958-2977, 2017 Nov 01.
Article in English | MEDLINE | ID: mdl-28877984

ABSTRACT

Tumors are fibrotic and characterized by abundant, remodeled, and cross-linked collagen that stiffens the extracellular matrix stroma. The stiffened collagenous stroma fosters malignant transformation of the tissue by increasing tumor cell tension to promote focal adhesion formation and potentiate growth factor receptor signaling through kinase. Importantly, collagen cross-linking requires fibronectin (FN). Fibrotic tumors contain abundant FN, and tumor cells frequently up-regulate the FN receptor α5ß1 integrin. Using transgenic and xenograft models and tunable two- and three-dimensional substrates, we show that FN-bound α5ß1 integrin promotes tension-dependent malignant transformation through engagement of the synergy site that enhances integrin adhesion force. We determined that ligation of the synergy site of FN permits tumor cells to engage a zyxin-stabilized, vinculin-linked scaffold that facilitates nucleation of phosphatidylinositol (3,4,5)-triphosphate at the plasma membrane to enhance phosphoinositide 3-kinase (PI3K)-dependent tumor cell invasion. The data explain why rigid collagen fibrils potentiate PI3K activation to promote malignancy and offer a perspective regarding the consistent up-regulation of α5ß1 integrin and FN in many tumors and their correlation with cancer aggression.


Subject(s)
Cell Adhesion/physiology , Fibronectins/metabolism , Integrin alpha5beta1/metabolism , Animals , Breast/metabolism , Cell Membrane/metabolism , Cells, Cultured , Cytokines/metabolism , Epithelial Cells/metabolism , Extracellular Matrix/metabolism , Female , Heterografts , Humans , Integrins/metabolism , Mice , Mice, Transgenic , Neoplasms/metabolism , Phosphatidylinositol 3-Kinases/metabolism , Signal Transduction
6.
Oncogene ; 36(9): 1276-1286, 2017 03 02.
Article in English | MEDLINE | ID: mdl-27546618

ABSTRACT

The transcription factor nuclear factor-κB (NF-κB) has important roles for tumorigenesis, but how it regulates cancer stem cells (CSCs) remains largely unclear. We identified insulin-like growth factor 2 (IGF2) is a key target of NF-κB activated by HER2/HER3 signaling to form tumor spheres in breast cancer cells. The IGF2 receptor, IGF1 R, was expressed at high levels in CSC-enriched populations in primary breast cancer cells. Moreover, IGF2-PI3K (IGF2-phosphatidyl inositol 3 kinase) signaling induced expression of a stemness transcription factor, inhibitor of DNA-binding 1 (ID1), and IGF2 itself. ID1 knockdown greatly reduced IGF2 expression, and tumor sphere formation. Finally, treatment with anti-IGF1/2 antibodies blocked tumorigenesis derived from the IGF1Rhigh CSC-enriched population in a patient-derived xenograft model. Thus, NF-κB may trigger IGF2-ID1-IGF2-positive feedback circuits that allow cancer stem-like cells to appear. Then, they may become addicted to the circuits. As the circuits are the Achilles' heels of CSCs, it will be critical to break them for eradication of CSCs.


Subject(s)
Breast Neoplasms/pathology , Gene Expression Regulation, Neoplastic , Inhibitor of Differentiation Protein 1/metabolism , Insulin-Like Growth Factor II/metabolism , Neoplasm Recurrence, Local/pathology , Neoplastic Stem Cells/pathology , Animals , Biomarkers, Tumor/genetics , Biomarkers, Tumor/metabolism , Breast Neoplasms/genetics , Breast Neoplasms/metabolism , Carcinogenesis , Female , Humans , Inhibitor of Differentiation Protein 1/genetics , Insulin-Like Growth Factor I/genetics , Insulin-Like Growth Factor I/metabolism , Insulin-Like Growth Factor II/genetics , Mice , Mice, Nude , NF-kappa B/genetics , NF-kappa B/metabolism , Neoplasm Grading , Neoplasm Invasiveness , Neoplasm Metastasis , Neoplasm Recurrence, Local/genetics , Neoplasm Recurrence, Local/metabolism , Neoplastic Stem Cells/metabolism , Phosphatidylinositol 3-Kinase/genetics , Phosphatidylinositol 3-Kinase/metabolism , Prognosis , Signal Transduction , Spheroids, Cellular , Survival Rate , Tumor Cells, Cultured , Xenograft Model Antitumor Assays
7.
Psychiatriki ; 27(2): 144-7, 2016.
Article in Greek | MEDLINE | ID: mdl-27467035

ABSTRACT

Thyroid hormones are crucial in adult brain metabolic activity. As a result, abnormal thyroid gland function and in particular hypofunction, might cause principally depression and neurocognitive dysfunction. Psychosis, presented mainly with thought disorders and perceptual disturbances, is a much rarer manifestation of hypothyreoidism. A correlation between hypothyreoidism and psychosis has been described since 1888, especially in cases of advanced hypothyreoidism. A few years later (1949), Asher first added the terminology "myxedema madness" to the literature. Psychotic symptoms typically appear after the onset of physical symptoms, usually with a delay of months or years. The case of a female patient who presented a psychotic episode as a first manifestation of hypothyroidism will be described. NE, a 48 yearold female patient, was admitted for the first time to an inpatient mental health care unit due to delusions of persecution and reference, as well as auditory hallucinations that appeared a few weeks ago. After the patient admission, routine laboratory examination was conducted. In order to relieve the patient from her sense of discomfort and while awaiting laboratory results, olanzapine, 5 mg/day, was administered. Neurological examination and cranial computed tomography scan were unremarkable. Hormonal laboratory tests though revealed severe low thyroid hormone levels. Thyroid antibody testing certified Hashimoto's thyroiditis. Olanzapine was discontinued and the patient received thyroid hormone substitution, levothyroxine 75 µg/day, instead. The patient was discharged showing a significant improvement of psychotic symptoms after a 12-day hospitalization. A month later the patient was reevaluated. She had fully recovered from the psychotic episode. A year later, the patient continues to remain free from psychiatric symptoms, while thyroid hormone levels have been restored within normal range. The patient continues receiving only thyroid hormone substitution therapy with levothyroxine. Cases of acute psychosis associated with low levels of thyroid hormones in the context of primary hypothyreoidism have been repeatedly reported. The present case report emphasizes the importance of hypothyroidism exclusion as a secondary cause of psychosis. Thyroid disease treatment ameliorates psychotic disorder symptoms and recovers patients' mental condition.


Subject(s)
Benzodiazepines/administration & dosage , Hashimoto Disease , Psychotic Disorders , Thyroxine/administration & dosage , Antipsychotic Agents/administration & dosage , Female , Hallucinations/diagnosis , Hashimoto Disease/blood , Hashimoto Disease/complications , Hashimoto Disease/diagnosis , Hashimoto Disease/psychology , Hormone Replacement Therapy/methods , Humans , Middle Aged , Olanzapine , Psychiatric Status Rating Scales , Psychotic Disorders/blood , Psychotic Disorders/drug therapy , Psychotic Disorders/etiology , Psychotic Disorders/physiopathology , Thyroid Hormones/blood , Treatment Outcome
9.
Braz. j. med. biol. res ; 45(10): 891-897, Oct. 2012. tab
Article in English | LILACS | ID: lil-647746

ABSTRACT

Polymorphisms of hormone receptor genes have been linked to modifications in reproductive factors and to an increased risk of breast cancer (BC). In the present study, we have determined the allelic and genotypic frequencies of the ERα-397 PvuII C/T, ERα-351 XbaI A/G and PGR PROGINS polymorphisms and investigated their relationship with mammographic density, body mass index (BMI) and other risk factors for BC. A consecutive and unselected sample of 750 Brazilian BC-unaffected women enrolled in a mammography screening program was recruited. The distribution of PGR PROGINS genotypic frequencies was 72.5, 25.5 and 2.0% for A1A1, A1A2 and A2A2, respectively, which was equivalent to that encountered in other studies with healthy women. The distribution of ERα genotypes was: ERα-397 PvuII C/T: 32.3% TT, 47.5% TC, and 20.2% CC; ERα-351 XbaI A/G: 46.3% AA, 41.7% AG and 12.0% GG. ERα haplotypes were 53.5% PX, 14.3% Px, 0.3% pX, and 32.0% px. These were significantly different from most previously published reports worldwide (P < 0.05). Overall, the PGR PROGINS genotypes A2A2 and A1A2 were associated with fatty and moderately fatty breast tissue. The same genotypes were also associated with a high BMI in postmenopausal women. In addition, the ERα-351 XbaI GG genotype was associated with menarche ≥12 years (P = 0.02). ERα and PGR polymorphisms have a phenotypic effect and may play an important role in BC risk determination. Finally, if confirmed in BC patients, these associations could have important implications for mammographic screening and strategies and may be helpful to identify women at higher risk for the disease.


Subject(s)
Adult , Aged , Female , Humans , Middle Aged , Breast Neoplasms/genetics , Deoxyribonucleases, Type II Site-Specific/genetics , Estrogen Receptor alpha/genetics , Genetic Predisposition to Disease , Polymorphism, Genetic/genetics , Receptors, Progesterone/genetics , Body Mass Index , Brazil , Breast Neoplasms/diagnosis , Gene Frequency , Genotype , Mammary Glands, Human/abnormalities , Prevalence , Risk Factors
10.
Neurocase ; 18(5): 377-85, 2012.
Article in English | MEDLINE | ID: mdl-22145931

ABSTRACT

The purpose of this study was to assess the predictors of functional outcome after right hemisphere stroke at 6-month follow up in patients with or without thrombolytic treatment. Thrombolysis did not predict functional outcome in instrumental activities of daily living (IADL). Lower acute phase basic activities of daily living (ADL) measured by the Barthel Index was a statistically significant predictor of IADL when adjusted for age and education (p = .015) and had borderline significance (p = .076) as a predictor of functional outcome when adjusted for severity of stroke at admission. When stroke severity was taken into account also higher age became a statistically significant (p = .039) predictor of functional outcome. The acute phase neuropsychological symptoms predicted the functional outcome in unadjusted analyses but when adjusted for age, education, and severity of stroke no independent association was found.


Subject(s)
Activities of Daily Living , Brain Ischemia/psychology , Perceptual Disorders/psychology , Recovery of Function/physiology , Stroke/psychology , Thrombolytic Therapy , Adult , Age Factors , Aged , Brain Ischemia/complications , Brain Ischemia/drug therapy , Disability Evaluation , Female , Humans , Male , Middle Aged , Neuropsychological Tests , Perceptual Disorders/etiology , Predictive Value of Tests , Severity of Illness Index , Stroke/complications , Stroke/drug therapy , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL